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Abstract: Dementia is an inevitable disease of aging, leading not only to diminished cognitive ability but also behavioral changes,
malnutrition, pressure sores, and infections. Acknowledging common problems and their solutions is essential for any health service
worker who deals with demented geriatric patients.
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1. Introduction
Dementia is defined as a progressive decline in cognitive
functions that interacts with activities of daily living,
causing dependency while performing tasks such as
bathing, eating, and ambulation. Reversible conditions
such as hypothyroidism, vitamin B12 deficiency,
intracranial lesions, normal pressure hydrocephalus,
subdural hematoma, and drugs can result in symptoms
resembling dementia and resolve after appropriate medical
or surgical therapy. However, the leading cause of dementia
is Alzheimer disease and current medications can only
slow its progression. Advanced age, female sex, low level of
education, and genetic factors increase the risk of cognitive
impairment. In addition, metabolic and vascular risk factors
like smoking, diabetes, hyperlipidemia, hypertension,
and obesity play roles in the development of dementia.
As a result of more common vaccination programs and
better sanitation, expected survival at birth has increased
worldwide over the last 5 decades. Therefore, the aging
population became a major problem of western countries
due to its burden on health care services devoted to older
patients. More and more patients with dementia are admitted
to hospitals for complications like infections, pressure
sores, and feeding problems. Malnutrition is important and
should be prevented; otherwise, susceptibility to infection,
development of pressure sores, and immobilization due
to sarcopenia will ensue. Demented patients are prone to
malnutrition owing to many different conditions such as
edentulism, dysphagia, and financial and social restrictions.
Their caregivers are also at risk of malnutrition (1). This
review will focus on common nutritional problems of
patients with dementia and their management.
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2. Common problems
2.1. Oral health
Edentulism, poorly fitting dentures, and alterations in the
sense of taste and smell of the foods by aging can lead to
malnutrition by decreasing solid food intake (2). Thus,
optimization of oral health is mandatory to maintain
adequate nutrition. In addition, cognitive impairment itself
can threaten oral health (3). Gil-Montoya et al. reported
that the Oral Health Impact Profile (OHIP), a 14-item
questionnaire, was able to detect malnutrition presence and
risk effectively in geriatric patients. Malnutrition/risk was
3.43-fold more prevalent in patients with OHIP-reported
problems than in those who did not report any problems (4).
Several studies reported an association between oral health
and malnutrition. Furuta et al., in their study conducted
among 286 dementia patients receiving home-care services,
reported that cognitive impairment, denture wearing, and
number of teeth affected nutritional status by interacting
with swallowing function, leading to malnutrition and
restriction in activities of daily living (5). Dion et al.
indicated the importance of regular dental examination in
order to prevent malnutrition in a study performed among
1094 geriatric institutionalized patients (6).
2.2. Dysphagia
Dysphagia, defined as difficulty in swallowing, is a late
clinical finding of patients with frontotemporal dementia,
while patients with Alzheimer disease, esophagus diseases,
neurologic disorders, and cerebrovascular accidents may
present with it initially. Various methods to confirm
dysphagia and aspiration are available, such as bed-side
sipping tests and fluoroscopic imaging. It is a major risk
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factor for aspiration pneumonia and consequent mortality.
In a previous study, geriatric patients with pneumonia who
were found to suffer from dysphagia had a higher 1-year
mortality rate compared to patients without dysphagia
(55.4% vs. 26.7%, P = 0.001). It was also reported to be
causative of malnutrition (7). In a Dutch study including
8119 care-home residents, subjective dysphagia was
reported in 9% of participants and particularly in 10.9%
of residents with dementia. Malnutrition was reported
to be associated with subjective dysphagia (OR: 1.58,
95%: CI 1.31–1.90, P < 0.001) (8). A systematic review
encompassing the medical literature between 1990
and 2011 about oropharyngeal dysphagia reported its
prevalence as 13%–57% and also concluded that preventive
measures, medications, and percutaneous endoscopic
gastrostomy placement were not proven to be beneficial
(9). In another review focusing on dysphagia in the elderly,
intensive swallowing rehabilitation was recommended as
a useful measure to decrease malnutrition and aspiration
pneumonia incidence (10). A multicenter study conducted
in Belgium assessed the prevalence of malnutrition and
associated factors in 2329 geriatric patients. Dysphagia
resulted in a 4.92-fold increased risk of malnutrition, as
the leading cause among other patient characteristics (11).
2.3. Vitamin B12 and folate deficiencies
Patients with dementia have a tendency for macroand micronutrient deficiencies. Deficiencies of certain
micronutrients are suspected to be responsible in the
pathogenesis of dementia and vice versa. Vitamin B12 is
an important molecule in terms of mental functionality.
It is well known that prevalence of vitamin B12 deficiency
increases with age. Insufficient oral intake is suggested
to be responsible; however, its impact on deficiency is
controversial. Thus, it is hard to infer that vitamin B12 is
deficient in demented patients due to malnutrition. The
most common mechanism suggested to explain vitamin
B12 deficiency in the elderly is atrophic gastritis and
consequent malabsorption. In addition, drugs can impair
absorption of vitamin B12. Defects in transportation
of vitamin B12 are being evaluated (12). Vitamin B12
deficiency, as an etiologic agent in dementia, was
investigated in several autopsy and intervention studies.
Inada et al. reported that histopathologic examination of
brains of patients with dementia revealed tissue deficiency
of vitamin B12 and consequent demyelination, neuronal
loss, and atrophy (13). Many trials were conducted
to find out the relationship between vitamin B12 and
cognitive impairment; however, the precise mechanism
still waits to be found (14–19). Subclinical deficiency of

vitamin B12 and cognitive impairment incidence is also
under investigation (20–22). Hyperhomocysteinemia
was considered to be a major vascular risk factor in
recent trials and is secondary to folate deficiency. Folate
deficiency has the potential to impair cognition via
different pathways including mitochondrial dysfunction
and consequent oxidative stress, loss of calcium regulation,
neuronal and synaptic impairment, and β-amyloid and
hyperphosphorylated tau accumulation. The effect of
hyperhomocysteinemia on development of dementia
was indicated in an animal model. A folate-deficient diet
resulted in hyperhomocysteinemia, which in turn caused
β-amyloid accumulation in the plasma and brains of young
and older mice, respectively (23). Therefore, supplementing
folate and B12 to maintain their levels over the low/normal
threshold (>14 nmol/L for folate and >220 pmol/L for B12)
is reasonable (24). Although results of numerous trials are
inconclusive, some observations need to be mentioned.
Hyperhomocysteinemia and folate deficiency are related to
dementia and Alzheimer disease; however, that is not true
for vitamin B12 deficiency. Hyperhomocysteinemia and
folate deficiency negatively affect information processing
and memory function, respectively; however, reversal
of the biochemical alteration ameliorates clinical status.
Vitamin B12 deficiency markers such as methylmalonic
acid elevation are related to both of the aforementioned
problems. Circulating vitamin B12 decrease is a sign for
accelerated global cognitive decline. Overtreatment of folate
deficiency results in deterioration of memory function,
information processing, and global cognition (25).
2.4. Vitamin D deficiency
Vitamin D is a steroid hormone that is acquired from
food as ergocalciferol (D2) and cholecalciferol (D3). It is
synthesized in the skin with the aid of ultraviolet radiation
and hepatic and renal activation by hydroxylation
ensues. Miscellaneous health problems are reported to
be related to its deficiency, such as sepsis, cardiovascular
and metabolic problems, and neoplastic disorders.
Recommended daily intake ascends with age, because
physiologic decrease of its synthesis and indoor living
contribute to deficiency. Dementia involves multiple risk
factors of vitamin D deficiency, such as advanced age,
diminished oral intake, and insufficient sunlight exposure
due to institutionalization. Daily intake of at least 800 IU
is appropriate for the healthy geriatric population, and up
to 4000 IU/day is tolerable (26). A recent metaanalysis that
included 6 studies of Alzheimer disease and 5 studies of
Parkinson disease revealed that these 2 common problems
of older people render them vulnerable to vitamin D
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deficiency as compared to healthy age-matched individuals
(27). From a different point of view, deficiency of vitamin
D is reported to be causative of Alzheimer disease. MicroRNA, toll-like receptors, vascular endothelial growth
factor, angiogenin, advanced glycation end products,
major histocompatibility complex class II, vitamin D
receptor, apolipoprotein E, liver X receptor, SpI promoter
gene, and the poly (ADP-ribose) polymerase-I gene are
proteins associated with Alzheimer disease pathology.
Furthermore, calcium sensing receptor, amyloid β,
interleukin-10,
matrix
metalloproteinases,
heme
oxygenase-1, reduced NADP, L-type voltage-sensitive
calcium channels, nerve growth factor, prostaglandins,
cyclooxygenase 2, reactive oxygen species, and nitric oxide
synthase are mediators of vitamin D-driven Alzheimer
disease development (28,29). Even before diagnosis of
manifest Alzheimer disease, vitamin D was shown to be
associated with mild cognitive impairment (MCI) in a
French study comparing 95 participants with MCI and
normal cognitive function. In that study, the odds ratio
of the lowest quartile of vitamin D status for the presence
of MCI was 25.46 and patients with MCI had lower mean
vitamin D concentrations (30). In another cross-sectional
study including 159 patients with a mean age of 85 years,
vitamin D deficiency was associated with increased falls
and impaired cognitive function; however, muscle strength
and balance was preserved. The authors concluded that
vitamin D deficiency resulted in cognitive decline, which
in turn increased falls, but due to the design of the study it
was impossible to conclude a causal relationship (31).
2.5. Micronutrient deficiencies
Micronutrients are essential minerals and vitamins of
utmost importance to maintain vital reactions. They
are also reported to play a role in Alzheimer disease

physiopathology. Cardiovascular disease and cancer
are associated with their deficiency, as well (32). In
a large metaanalysis covering 80 eligible trials about
micronutrients, low levels of vitamin B12, A, E, and C and
folate were found to be associated with Alzheimer disease.
On the other hand, plasma copper and iron levels were not
different between Alzheimer disease patients and healthy
controls. It was concluded that insufficient utilization
of these molecules was followed by protein and energy
malnutrition, which is a classical problem of apparent
dementia. Therefore, nutritional interventions may have
the potential to prevent progression of dementia long
before irreversible cognitive deficit develops (33). Though
the current literature is inconclusive for making definite
recommendations on the ideal micronutrient composition
of regular diets, consumption of fish, vegetable oils,
nonstarchy vegetables, and fruits with low glycemic
indexes is recommended to reduce the risk of dementia
and other nutrition-associated health conditions. Even
popular diets like the Mediterranean diet and dietary
approaches to stop hypertension lack enough evidence to
become guideline recommendations in terms of slowing
cognitive performance loss (34).
Common nutritional problems, their clinical
manifestations, their relationships with dementia severity,
and recommendations to overcome them are summarized
in Table 1.
2.6. Interventions to improve nutritional status
Oral nutritional supplements (ONSs) are drinks that
contain the needed macro- and micronutrients. They
are indicated in the case of malnutrition or malnutrition
risk due to various disorders (35). A recent metaanalysis
depicting their efficacy reported that they were efficient
in providing enough energy, and slight weight gain
ensued. Some of those studies showed that Mini Mental

Table 1. Common nutritional problems, their manifestations, their relationships with dementia severity, and recommendations.
Common problems

Dementia severity

Manifestation

Recommendations

Oral health problems

Any stage

Impaired swallowing function due to
edentulism or poor oral hygiene

Dentures, dental implants, tooth
brushing, regular dentist visits

Dysphagia

Moderate to advanced
dementia

Aspiration pneumonia

Intensive swallowing rehabilitation

Vitamin B12 and folate
deficiencies

Any stage

Impaired cognitive ability, paresthesias,
falls, rarely anemia

Replacement to ensure levels over low/
normal thresholds (>14 nmol/L for folate
and >220 pmol/L for B12)

Vitamin D deficiency

Any stage

Falls, common bone pain, muscle
weakness

Daily intake of 800 IU vitamin D

Micronutrient deficiencies

Advanced dementia

Associated with a huge range of different
conditions such as cardiovascular
problems, cancer, and dementia

Consumption of fish, vegetable oils,
nonstarchy vegetables, and fruits with
low glycemic indexes
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State Examination scores improved after ONS usage;
however, their effectiveness is still debated. The most
expected problem of insufficient adherence to drinks was
reported to be significant in only 1 of 12 studies (36). Even
the serving method can matter. Allen et al. analyzed 45
older patients with cognitive impairment and reported
that the consumption of ONSs increased if they were
served in a glass rather than by a straw inserted directly
into the container (37). Administration of nutrients via a
tube inserted into the stomach is an alternative to ONSs
and can easily be emplaced by the guide of endoscopy.
Percutaneous endoscopic gastrostomy (PEG) placement is
a common procedure of increasing popularity, particularly
in Alzheimer disease patients (38). However, it is not
beneficial to use PEG in patients with end-stage cancer
or other end-stage diseases and advanced dementia. Early
intervention to improve nutritional status is preferred to
terminal palliative intervention. PEG usage is expected
to prevent malnutrition and aspiration in patients with
dementia; however, trials showed that none of these
endpoints were met (39). The last resort is parenteral
nutrition for patients who are unable to be fed via the
enteral route or whose enteral nutrition does not meet
protein and energy goals. Except for terminal dementia,
administration of parenteral nutrition is a valuable
method. Its role in patients with advanced dementia is
unclear (40). Behavioral therapy was shown to be effective
for better nutrition; nevertheless, scarcity of trained staff

limits its availability (41). Pros and cons of interventions to
prevent and treat malnutrition are summarized in Table 2.
3. Conclusions
In this review, individualized patient care is emphasized.
As contributors of malnutrition in a patient with
dementia, optimizing oral health and managing dysphagia
is important. Fortifying the macro- and micronutrients via
the optimal route is a major challenge in demented elderly
patients due to the complexity of the disease itself and
conflicting ethical issues about end-of-life management.
However, it seems a rational approach to prefer ONSs
over other options due to their ease of administration and
relatively lower rate of complications in order to maintain
adequate caloric intake. In addition, many dementia
patients are bedridden or live indoors, deprived of sunlight;
for this reason, they have a tendency to develop sarcopenia
and osteomalacia. Most ONSs contain the recommended
daily intake of micronutrients and vitamin D. Despite the
great variation in practice among different countries, tube
feeding is not recommended in patients with advanced
dementia as it is not proven to be more beneficial than
hand feeding. Therefore, tube feeding should be limited to
early-stage dementia patients who suffer from dysphagia
and consequent aspiration pneumonia. Parenteral
nutrition may be useful for patients with certain conditions
in which we need to by-pass the gastrointestinal tract.
Nevertheless, it should be reserved as a last resort because
of its burdensome complications.

Table 2. Pros and cons of interventions to prevent and treat malnutrition.
Methods

Pros

Cons

Oral nutritional
supplements

Low cost
Physiological
Maintains the satisfaction of tasting

Adherence to drinks is low in long-term administration
May cause diarrhea

Tube feeding

Aspiration risk is expected to decrease
in cases of dysphagia
Physiological
A safe way to administer enough caloric
intake
An easy route of nutrition for the
caregiver, bypassing the need for hand
feeding

Needs a procedure to apply
May cause diarrhea
Aspiration/malnutrition incidence is not proven to be as low as
expected
Blockage of tube and entry-site skin reactions are possible
problems leading to recurrent hospitalization
Displacement of tube is common in delirious patients, leading
to usage of physical and chemical restraints

Parenteral nutrition

Effective way of nutritional
supplementation

Expensive
Hard to apply in community-dwelling patients
Possible biochemical abnormalities
Risk of hypervolemia
Nonphysiological, threatens enteral mucosal integrity and
increases the risk of bacterial translocation

Behavioral therapy

Low cost
No adverse effects

Limited availability due to lack of enough trained staff
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